31 January 2017 - Pfizer Inc Chief Executive Ian Read said on Tuesday the company would not change its philosophy on pricing of its medicines or when it takes price increases, bucking a recent trend by some rivals of the largest U.S. drugmaker.

The comments, made on a conference call after Pfizer reported slightly lower than expected fourth-quarter profit, came as several of Read's industry peers met with U.S. President Donald Trump, who has insisted prescription drug prices must come down.

Discussions with Trump included some ideas on how that goal might be accomplished, including tax reform and undoing regulations that slow entry of new drugs and generics to the market.

Read Daily Mail article